Categories: NewsPharmaceutical

Assertio Holdings, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023

LAKE FOREST, Ill., April 27, 2023 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.

To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-929-201-5912.

A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

About Assertio
Assertio is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. We have built and continue to build our commercial portfolio by identifying new opportunities within our existing products as well as acquisitions or licensing of additional approved products. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact
Matt Kreps
Darrow Associates Investor Relations
+1-214-597-8200
mkreps@darrowir.com  

Staff

Recent Posts

MyndTec Inc. Completes Sixth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - June 24, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the…

30 mins ago

Independent Pharmacy Cooperative (IPC) and McKesson Forge New Supply Agreement

SUN PRAIRIE, Wis., June 24, 2024 /PRNewswire/ -- Independent Pharmacy Cooperative (IPC), a leading group…

2 hours ago

Danaher Schedules Second Quarter 2024 Earnings Conference Call

WASHINGTON, June 24, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its…

2 hours ago

Illumina completes the divestiture of GRAIL

GRAIL spin-off complete; GRAIL to begin regular way trading as "GRAL" on June 25Illumina to…

2 hours ago

Healcisio Receives Phase II STTR Funding to Continue Critical Care AI Research

SAN DIEGO, June 24, 2024 /PRNewswire/ -- Healcisio, a leader in AI and digital healthcare,…

2 hours ago